According to a study published on April 30, 2026, in Hepatobiliary & Pancreatic Diseases International, a combined bio-histological framework known as the Seven-Up score can substantially reduce overtreatment of early T cell-mediated rejection (TCMR) after liver transplantation. Conducted at Université catholique de Louvain in Brussels, Belgium, under the leadership of Prof. Jan P. Lerut, the … Read more
Nathaniel Zachariah Tan, who died at age 27 from a rare brain disease last August, saved at least three lives through organ donation. According to the National Organ Transplant Unit (NOTU), Tan’s liver and kidneys were transplanted into three separate patients, while his iliac vessels remain stored for future surgeries. NOTU confirms impact of Nathaniel … Read more
According to a study published in BMC Biology, researchers at the USC Dornsife College of Letters, Arts and Sciences and Howard University have discovered that modern human immune responses bear genetic marks of ancient battles with infectious diseases, while also identifying rare variants linked to severe COVID-19. The findings bridge human evolution and infectious disease. … Read more
Solid-organ transplant recipients face a significantly higher risk of mortality if they develop diabetes, according to a comprehensive analysis presented at ENDO 2026, the Endocrine Society’s annual meeting. Researchers analyzed data from over 800,000 U.S. patients who underwent transplants between 2003 and 2021, finding that both pre-existing and post-surgery diabetes consistently reduced long-term survival rates … Read more
Engineering the Future of Regenerative Medicine: Lab-Grown Gut Tissue A breakthrough in organoid research is changing the landscape of regenerative medicine. Researchers at Cincinnati Children’s have developed a new “confined culture system” (CCS) that allows for the production of functional human gut organoids at a significantly accelerated pace and increased scale. Cincinnati Children By utilizing … Read more
Turning Routine Screening Into a Window for Longevity For decades, the medical community has understood that the immune system is a primary driver of the aging process. As we grow older, we often see a decline in vaccination efficacy, an increase in infection risks and rising levels of systemic inflammation. However, the challenge has always … Read more
The Rise of “Companion Wellness”: Managing the GLP-1 Era We are witnessing a paradigm shift in the pharmaceutical landscape. The explosive popularity of GLP-1 receptor agonists for weight loss and diabetes management has created an unexpected ripple effect: the emergence of a “companion wellness” market. As millions of users achieve their health goals, they are … Read more
Overcoming the “Cell Count” Hurdle in Cord Blood Transplants For years, umbilical cord blood has been a beacon of hope for patients with blood cancers and other hematologic diseases. Unlike bone marrow, cord blood stem cells do not require a stringent match to be effective, making them a vital resource for patients who lack a … Read more
The Evolution of COVID-19 Treatment: From Broad Application to Precision Care The landscape of antiviral treatment is shifting. For years, the primary goal of early intervention with Paxlovid (nirmatrelvir-ritonavir) was the prevention of severe outcomes, such as hospitalization and death. However, as vaccination rates have climbed, the clinical utility of these treatments is evolving. View … Read more
The High Stakes of Heart Transplant Decisions: Why AI is the New Frontier In the United States, the shortage of heart donors is a critical crisis. Thousands of patients remain on transplant waitlists, often relying on life support in intensive care units whereas waiting months for a compatible organ. However, the problem isn’t just a … Read more